Lysocardiolipin Acyltransferase 1 (LCLAT1) Peptide
LCLAT1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all LCLAT1 products
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YLYSLVKWYF IITIVIFVLQ ERIFGGLEII ELACYRLLHK QPHLNSKKNE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LYCAT antibody,
Alternative Names: LYCAT control peptide, LYCAT antibody Blocking Peptide, Anti-LYCAT Blocking Peptide, Lysocardiolipin Acyltransferase Blocking Peptide, ALCAT1 Blocking Peptide, FLJ37965 Blocking Peptide, UNQ1849 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
- Background
- LYCAT is an acyl-CoA:lysocardiolipin acyltransferase. It possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. LYCAT recognises both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. LYCAT acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. It converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. LYCAT is required for establishment of the hematopoietic and endothelial lineages.
- Molecular Weight
- 44 kDa
-
You are here:
